After the recent announcement of acquisitions, Medicine Man (MDCL) could be trading at 6x sales. Considering that competitors in the cannabis industry are trading at 9x-47x sales, Medicine Man seems to be very undervalued. Since the new transactions were announced in September, the share price increased by more than 25%. We believe that the upward trend may continue.
Business
Founded in 2014, Medicine Man is a cannabis consulting company providing services about cost-efficient cultivation technologies, and dispensary operating solutions among others. The image and the lines below describe Medicine Man's business model in